DEFINITIVE PROXY STATEMENT

Company

BRAINSTORM CELL THERAPEUTICS INC.

Filed

May 7, 2012

Period of Report

June 12, 2012

Accession Number

0001144204-12-026585

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →